Search company, investor...

Predict your next investment

Getinge company logo
Corporation
HEALTHCARE | Medical Devices & Equipment
getinge.com

Partners & Customers

10

About Getinge

Getinge is a medical technology company. The company provides equipment, systems, operating rooms, and intensive-care units to the healthcare and the life science industries. The company also operates through the following businesses: Acute Care Therapies, Patient & Post-Acute Care, and Surgical Workflows.

Headquarters Location

Lindholmspiren 7

Gothenburg, SE-402 72,

Sweden

+46 (0)10 335 0000

Want to inform investors similar to Getinge about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Getinge News

Jeanette Hedén Carlsson resigns as Executive Vice President Brand & Communication at Getinge

Sep 19, 2023

Getinge Tue, Sep 19, 2023 14:00 CET Getinge announces that Jeanette Hedén Carlsson has decided to resign after 6 years as Executive Vice President, Brand & Communication, and member of the Executive Team. The process to recruit a successor will start immediately. ”Jeanette has successfully built and developed effective communication and investor engagement, which are important parts of our growth strategy”, says Mattias Perjos, President & CEO at Getinge. “Under her leadership Getinge’s brand recognition has increased on our key markets. I have appreciated her as a colleague and wish her all the best in her next career step”. Jeanette Hedén Carlsson will continue in her current role until December 31, 2023. Media contact:

Getinge Acquisitions

11 Acquisitions

Getinge acquired 11 companies. Their latest acquisition was High Purity New England on May 31, 2023.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

5/31/2023

$99M

Acquired

5

3/14/2023

$99M

Acquired

4

4/28/2022

Series A

$99M

$3.61M

Acquired

1

12/23/2021

Subscribe to see more

$99M

Subscribe to see more

10

11/12/2021

Debt

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

5/31/2023

3/14/2023

4/28/2022

12/23/2021

11/12/2021

Investment Stage

Series A

Debt

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$3.61M

$99M

Note

Acquired

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

5

4

1

10

10

Getinge Partners & Customers

10 Partners and customers

Getinge has 10 strategic partners and customers. Getinge recently partnered with Anaqua on June 6, 2023.

Date

Type

Business Partner

Country

News Snippet

Sources

6/6/2023

Vendor

United States

Getinge Selects Anaqua to Provide Single, Centralized IP Management Platform

BOSTON , June 06 , 2023 -- Anaqua , Inc. , the leading innovation and intellectual property management technology provider , today announced that global medical technology company Getinge has selected Anaqua , Inc. 's AQX in order to consolidate the management of all its IP assets onto a single , centralized platform .

3

9/20/2022

Client

United States

Getinge : partners with Medtronic for the manufacturing of the Radiant balloon-expandable covered stent

Getinge announces a supply partnership with Medtronic , which recently received CE mark for the Radiant ™ covered stent , the first covered stent indicated for chimney endovascular aneurysm repair .

4

6/12/2022

Partner

France

Getinge launches financing program with BNP Paribas Leasing Solutions

Getinge announces new partnership with BNP Paribas Leasing Solutions for innovative payment solutions for its European customers .

2

4/7/2022

Partner

United States

Subscribe to see more

Subscribe to see more

10

3/8/2022

Client

United States

Subscribe to see more

Subscribe to see more

10

Date

6/6/2023

9/20/2022

6/12/2022

4/7/2022

3/8/2022

Type

Vendor

Client

Partner

Partner

Client

Business Partner

Country

United States

United States

France

United States

United States

News Snippet

Getinge Selects Anaqua to Provide Single, Centralized IP Management Platform

BOSTON , June 06 , 2023 -- Anaqua , Inc. , the leading innovation and intellectual property management technology provider , today announced that global medical technology company Getinge has selected Anaqua , Inc. 's AQX in order to consolidate the management of all its IP assets onto a single , centralized platform .

Getinge : partners with Medtronic for the manufacturing of the Radiant balloon-expandable covered stent

Getinge announces a supply partnership with Medtronic , which recently received CE mark for the Radiant ™ covered stent , the first covered stent indicated for chimney endovascular aneurysm repair .

Getinge launches financing program with BNP Paribas Leasing Solutions

Getinge announces new partnership with BNP Paribas Leasing Solutions for innovative payment solutions for its European customers .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

4

2

10

10

Getinge Team

18 Team Members

Getinge has 18 team members, including current Managing Director, Chris Devlin.

Name

Work History

Title

Status

Chris Devlin

Managing Director

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Chris Devlin

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Managing Director

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Compare Getinge to Competitors

J
Jarvik Heart

Jarvik Heart is a private company that develops miniaturized heart assist devices for the treatment of severe heart failure.

Teleflex Logo
Teleflex

Teleflex (NYSE: TFX) manufactures and markets surgical instruments and devices in the United States and internationally. It offers surgical instruments, appliances, cardiac devices, and other products. Teleflex was formerly known as Hudson Respiratory Care. The company was founded in 1943 and is based in Wayne, Pennsylvania.

R
ReliantHeart

ReliantHeart is a provider in mechanical circulatory support therapies for advanced stage heart failure. The company manufactures the HeartAssist5, a next generation ventricular assist device (VAD) which has CE Mark approval for commercial sale in Europe. The HeartAssist5 is an implantable, electric pump designed for use in patients requiring ventricular support due to end stage heart failure and is the world's only remotely monitored VAD.

B
BiVACOR

BiVACOR develops an artificial heart-pumping device designed to take over the complete function of a patient's failing heart. The compact device comprises a magnetically levitated rotor located between opposing pump casings and leverages rotary blood pump technology to provide the required cardiac output. The company was founded in 2008 and is based in Houston, Texas.

Stryker Logo
Stryker

Stryker (NYSE: SYK) develops, manufactures, and markets specialty surgical and medical products worldwide. It offers orthopedic implants, trauma systems, powered surgical instruments, endoscopic systems, and, patient care and handling equipment. It was founded in 1941 and is based in Kalamazoo, Michigan.

ImaCor Logo
ImaCor

ImaCor designs, manufactures, and distributes hTEE technology, the first and only critical care solution enabling clinicians to optimize cardiac performance with continuously-available, direct cardiac visualization over time, collectively serving patients, clinicians, and hospital administrators with the best possible clinical outcomes and cost-effective resource utilization. hTEE technology is enabled through the ZuraTM ultrasound systems and the miniaturized, disposable ClariTEE probe, uniquely designed to remain indwelling for up to 72 hours for episodic assessment of cardiac filling and function. Direct visualization with hTEE enables clinicians to optimize cardiac performance throughout a patient's course of treatment, allowing them to guide and assess the effectiveness of therapies, as well as make critical changes in management at the right time.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.